The adjustment cycle of the National Essential Drugs List is generally three years. On the basis of keeping the quantity relatively stable, the National Essential Drugs List implements dynamic management and is adjusted once every three years in principle.
According to Article 9 of the "Measures for the Management of the National Essential Drug List", the National Essential Drug List implements dynamic management on the basis of keeping the quantity relatively stable, and in principle adjusts it once every three years. If necessary, adjustments can be made in a timely manner upon review and approval by the National Essential Medicines Working Committee. The varieties and quantities to be adjusted should be determined based on the following factors:
(1) Changes in my country’s basic medical and health needs and basic medical security levels;
(2) Changes in my country’s disease spectrum;
p>
(3) Monitoring and evaluation of adverse drug reactions;
(4) Monitoring and evaluation of the application of national essential drugs;
(5) Evidence-based medicine, Pharmacoeconomic evaluation;
(6) Other situations specified by the National Essential Medicines Working Committee.
Extended information:
Article 5 of the "Measures for the Administration of the National Essential Drug List" The chemical drugs, biological products, and Chinese patent medicines in the National Essential Drug List shall be listed in the "National Essential Drug List" *The varieties included in the Chinese Pharmacopoeia and drug standards published by the national food and drug regulatory authorities and the former Ministry of Health. Except for first-aid and rescue drugs, inclusion of exclusively produced varieties into the National Essential Drugs List shall be subject to separate verification.
The names of chemical drugs and biological products shall use the chemical ingredients expressed in the Chinese common name and the English international non-proprietary drug name, and the dosage forms shall be listed separately; Chinese patent medicines shall use the common name of the drug.
China National People’s Congress website - Measures for the Management of the National Essential Drug List